USSTOCK.TODAY
Market Closed
Log in Sign up

Supernus Pharmaceuticals to Announce Q3 Results Ahead of Merger with Indivior

Earnings Whispers ·

SUPN
SUPN Supernus Pharmaceuticals Inc
$42.07 +2.09%
View chart & analysis →
  1. 1Supernus Pharmaceuticals announced an all-stock merger with Indivior.
  2. 2Supernus's projected Q3 revenue is approximately $223.7 million, representing a 16.4% year-over-year increase.
  3. 3Supernus's projected Q3 earnings per share is $0.34.

So what's the key point?

Supernus Pharmaceuticals announced it will merge with Indivior. Revenue for this quarter is expected to increase by 16.4% compared to last year.

Source Earnings Whispers · View original ↗

Related 3-line summaries

Supernus jumps 18.75% premarket on strong sales and Indivior merger announcement InvestorsHub +5 · Aug 4Market skepticism grows ahead of Striker's Q3 earnings release Earnings Whispers · 8h agoStarz Entertainment Corp passes profitability trough in Q3, focuses on streaming transition Earnings Whispers · 8h ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news